At a glance
ClinicalIndex Comparison RecordN/ACompleted· 103 enrolled
Drug / intervention
Lidocaine injections +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Greater Occipital and Supraorbital Nerve Blockade For The Preventive Treatment of Migraine
Dr. Lutfi Kirdar Kartal Training and Research Hospital·interventional·Posted Feb 15, 2018·Updated Mar 23, 2022
In Brief
A clinical study evaluating Lidocaine injections and Saline injections for Migraine Disorders. Completed, enrolled 103 participants.
Detailed Summary
The investigators aimed to evaluate the efficacy of greater occipital nerve and supraorbital nerve blockade with local anesthetics for the preventive treatment of migraine without aura.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine Disorders
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartSep 2014
Primary CompletionJun 2015
Study CompletionJun 2016
First PostedFeb 2018
TodayJul 2026
First PostedFeb 15, 2018
Enrollment StartSep 1, 2014
Primary CompletionJun 1, 2015
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 8.4 years ago
Interventions
Lidocaine injectionsprocedure
Lidocaine injections. A mixture of 1 ml 2% lidocaine and 0.9% 1 ml saline was injected bilaterally to greater occipital nerve and supraorbital nerve in the blockade patients.
Saline injectionsprocedure
Saline injections. Patients received 2 ml 0.9% saline in bilaterally to greater occipital nerve and supraorbital nerve